FindTrial
Sign In

Genotyping of the RhD negative pregnant women

Genotyping of the RhD negative pregnant women

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RPC-17014205
Enrollment
Unknown
Registered
2017-12-28
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

RhD hemolytic disease of the newborns

Interventions

Pregnancy cohort:No

Sponsors

Dalian Blood Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Pregnant women; 2) RhD negative.

Exclusion criteria

Exclusion criteria: Hematopoietic stem cells or organ recipient.

Design outcomes

Primary

MeasureTime frame
HLA-B27;—

Countries

China

Contacts

Public ContactWang Ni

Dalian Blood Center

wangni0214@163.com+86 0411-82654539

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026